Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. Ma, J., Chen, Q., & Ma, S. Journal of Cellular and Molecular Medicine, 25(6):2764–2775, March, 2021. ![Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis.
@article{ma_left_2021,
title = {Left atrial fibrosis in atrial fibrillation: {Mechanisms}, clinical evaluation and management},
volume = {25},
issn = {1582-1838},
shorttitle = {Left atrial fibrosis in atrial fibrillation},
url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/},
doi = {10.1111/jcmm.16350},
abstract = {Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis.},
number = {6},
urldate = {2021-11-16},
journal = {Journal of Cellular and Molecular Medicine},
author = {Ma, Jin and Chen, Qiuxiong and Ma, Shiyu},
month = mar,
year = {2021},
pmid = {33576189},
pmcid = {PMC7957273},
pages = {2764--2775},
}
Downloads: 0
{"_id":"pg8RQZrNwEKMRALB4","bibbaseid":"ma-chen-ma-leftatrialfibrosisinatrialfibrillationmechanismsclinicalevaluationandmanagement-2021","author_short":["Ma, J.","Chen, Q.","Ma, S."],"bibdata":{"bibtype":"article","type":"article","title":"Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management","volume":"25","issn":"1582-1838","shorttitle":"Left atrial fibrosis in atrial fibrillation","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/","doi":"10.1111/jcmm.16350","abstract":"Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis.","number":"6","urldate":"2021-11-16","journal":"Journal of Cellular and Molecular Medicine","author":[{"propositions":[],"lastnames":["Ma"],"firstnames":["Jin"],"suffixes":[]},{"propositions":[],"lastnames":["Chen"],"firstnames":["Qiuxiong"],"suffixes":[]},{"propositions":[],"lastnames":["Ma"],"firstnames":["Shiyu"],"suffixes":[]}],"month":"March","year":"2021","pmid":"33576189","pmcid":"PMC7957273","pages":"2764–2775","bibtex":"@article{ma_left_2021,\n\ttitle = {Left atrial fibrosis in atrial fibrillation: {Mechanisms}, clinical evaluation and management},\n\tvolume = {25},\n\tissn = {1582-1838},\n\tshorttitle = {Left atrial fibrosis in atrial fibrillation},\n\turl = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/},\n\tdoi = {10.1111/jcmm.16350},\n\tabstract = {Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis.},\n\tnumber = {6},\n\turldate = {2021-11-16},\n\tjournal = {Journal of Cellular and Molecular Medicine},\n\tauthor = {Ma, Jin and Chen, Qiuxiong and Ma, Shiyu},\n\tmonth = mar,\n\tyear = {2021},\n\tpmid = {33576189},\n\tpmcid = {PMC7957273},\n\tpages = {2764--2775},\n}\n\n","author_short":["Ma, J.","Chen, Q.","Ma, S."],"key":"ma_left_2021-1","id":"ma_left_2021-1","bibbaseid":"ma-chen-ma-leftatrialfibrosisinatrialfibrillationmechanismsclinicalevaluationandmanagement-2021","role":"author","urls":{"Paper":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/jjAllen01","dataSources":["b2rH2vd6Bpc9f2j4b"],"keywords":[],"search_terms":["left","atrial","fibrosis","atrial","fibrillation","mechanisms","clinical","evaluation","management","ma","chen","ma"],"title":"Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management","year":2021}